A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†

Tony Reiman; Kerry J. Savage; Michael Crump; Matthew C. Cheung; David MacDonald; Rena Buckstein; Stephen Couban; Eugenia Piliotis; Kevin Imrie; David Spaner; Sudeep Shivakumar; John Kuruvilla; Diego Villa; Lois E. Shepherd; Tanya Skamene; Chad Winch; Bingshu E. Chen; Annette E. Hay

doi:10.1080/10428194.2018.1515937

A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†

Tony Reiman, Kerry J. Savage, Michael Crump, Matthew C. Cheung, David MacDonald, Rena Buckstein, Stephen Couban, Eugenia Piliotis, Kevin Imrie, David Spaner, Sudeep Shivakumar, John Kuruvilla, Diego Villa, Lois E. Shepherd, Tanya Skamene, Chad Winch, Bingshu E. Chen, Annette E. Hay

Research output: Contribution to journal › Article › peer-review

21 Citations (Scopus)

Original language	English
Pages (from-to)	912-919
Number of pages	8
Journal	Leukemia and Lymphoma
Volume	60
Issue number	4
DOIs	https://doi.org/10.1080/10428194.2018.1515937
Publication status	Published - Mar 21 2019
Externally published	Yes

ASJC Scopus Subject Areas

Hematology
Oncology
Cancer Research

Keywords

Non-Hodgkin lymphoma
combination therapy
phase I trial
romidepsin

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/10428194.2018.1515937

Fingerprint

Dive into the research topics of 'A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†'. Together they form a unique fingerprint.

Cite this

Reiman, T., Savage, K. J., Crump, M., Cheung, M. C., MacDonald, D., Buckstein, R., Couban, S., Piliotis, E., Imrie, K., Spaner, D., Shivakumar, S., Kuruvilla, J., Villa, D., Shepherd, L. E., Skamene, T., Winch, C., Chen, B. E., & Hay, A. E. (2019). A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†. Leukemia and Lymphoma, 60(4), 912-919. https://doi.org/10.1080/10428194.2018.1515937

A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†. / Reiman, Tony; Savage, Kerry J.; Crump, Michael et al.
In: Leukemia and Lymphoma, Vol. 60, No. 4, 21.03.2019, p. 912-919.

Research output: Contribution to journal › Article › peer-review

Reiman, T, Savage, KJ, Crump, M, Cheung, MC, MacDonald, D, Buckstein, R, Couban, S, Piliotis, E, Imrie, K, Spaner, D, Shivakumar, S, Kuruvilla, J, Villa, D, Shepherd, LE, Skamene, T, Winch, C, Chen, BE & Hay, AE 2019, 'A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†', Leukemia and Lymphoma, vol. 60, no. 4, pp. 912-919. https://doi.org/10.1080/10428194.2018.1515937

Reiman T, Savage KJ, Crump M, Cheung MC, MacDonald D, Buckstein R et al. A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†. Leukemia and Lymphoma. 2019 Mar 21;60(4):912-919. doi: 10.1080/10428194.2018.1515937

@article{53441e54501b44a39c78d4b305b3db2c,

title = "A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†",

keywords = "Non-Hodgkin lymphoma, combination therapy, phase I trial, romidepsin",

author = "Tony Reiman and Savage, {Kerry J.} and Michael Crump and Cheung, {Matthew C.} and David MacDonald and Rena Buckstein and Stephen Couban and Eugenia Piliotis and Kevin Imrie and David Spaner and Sudeep Shivakumar and John Kuruvilla and Diego Villa and Shepherd, {Lois E.} and Tanya Skamene and Chad Winch and Chen, {Bingshu E.} and Hay, {Annette E.}",

note = "Publisher Copyright: {\textcopyright} 2018, {\textcopyright} 2018 Informa UK Limited, trading as Taylor & Francis Group.",

year = "2019",

month = mar,

day = "21",

doi = "10.1080/10428194.2018.1515937",

language = "English",

volume = "60",

pages = "912--919",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "4",

}

TY - JOUR

T1 - A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†

AU - Reiman, Tony

AU - Savage, Kerry J.

AU - Crump, Michael

AU - Cheung, Matthew C.

AU - MacDonald, David

AU - Buckstein, Rena

AU - Couban, Stephen

AU - Piliotis, Eugenia

AU - Imrie, Kevin

AU - Spaner, David

AU - Shivakumar, Sudeep

AU - Kuruvilla, John

AU - Villa, Diego

AU - Shepherd, Lois E.

AU - Skamene, Tanya

AU - Winch, Chad

AU - Chen, Bingshu E.

AU - Hay, Annette E.

PY - 2019/3/21

Y1 - 2019/3/21

KW - Non-Hodgkin lymphoma

KW - combination therapy

KW - phase I trial

KW - romidepsin

UR - http://www.scopus.com/inward/record.url?scp=85054680037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054680037&partnerID=8YFLogxK

U2 - 10.1080/10428194.2018.1515937

DO - 10.1080/10428194.2018.1515937

M3 - Article

C2 - 30301414

AN - SCOPUS:85054680037

SN - 1042-8194

VL - 60

SP - 912

EP - 919

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 4

ER -

A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this